Toxicity of intravenous anaesthetics.
Intravenous anaesthetic agents are generally remarkably safe. However, it is clear that propofol infusion syndrome is a real, albeit rare, entity. This often lethal syndrome of metabolic acidosis, acute cardiomyopathy and skeletal myopathy is strongly associated with infusions of propofol at rates of 5 mg/kg/hour and greater for more than 48 hours. There is evidence to support the hypothesis that the syndrome is caused by the failure of free fatty acid metabolism due to inhibition of free fatty acid entry into the mitochondria and also specific sites in the mitochondrial respiratory chain. The syndrome therefore mimics the mitochondrial myopathies. Midazolam causes seizure-like activity in very-low-birthweight premature infants requiring the drug prior to tracheal intubation or during prolonged positive pressure ventilation. This can be successfully reversed with the specific benzodiazepine antagonist flumazenil. Midazolam can also cause paradoxical reactions, including increased agitation, poor co-operation and aggressive or violent behaviour, which has been successfully managed with flumazenil.
Department of Anaesthesia, Auckland Hospital, Park Road, Grafton, Auckland I, New Zealand.
Timothy G
TG
Short
Yatin
Y
Young
D018686:Anesthetics, Intravenous / Q000009:adverse effects*; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced; D007649:Ketamine / Q000009:adverse effects; D008874:Midazolam / Q000009:adverse effects; D009420:Nervous System / Q000187:drug effects; D010195:Pancreatitis / Q000139:chemically induced; D015742:Propofol / Q000378:metabolism / Q000633:toxicity
D018686:Anesthetics, Intravenous; D007649:Ketamine; D008874:Midazolam; D015742:Propofol